Stamceltherapie voor het beschadigde hart
Publication date
2016-04
Authors
van der Naald, Mira
Tseng, Cheyenne C S
Doevendans, Pieter
Chamuleau, Steven
Editors
Advisors
Supervisors
DOI
Document Type
Article
Metadata
Show full item recordCollections
License
Abstract
Current therapies for ischemic heart failure are not sufficient. Regenerative therapy is a promising strategy that has rapidly developed into a clinical phase. Although the exact mechanism of action is not entirely understood, clinical results show a statistically significant effect of stem cells in ischemic heart diseases. At this moment there is no consensus on the clinical relevance of stem cell therapy. In this review we discuss the rationale for stem cell therapy. We will focus on autologous bone marrow cells in clinical setting. Finally, we will give an overview of new developments that will optimize future cell therapy.
Keywords
Ischemic cardiomyopathy, ischemic heart disease, myocardial infarction, stem cell therapy, ischemische cardiomyopathie, ischemische hartziekte, myocardinfarct, stamceltherapie
Citation
van der Naald, M, Tseng, CCS, Doevendans, PA & Chamuleau, SAJ 2016, 'Stamceltherapie voor het beschadigde hart', Nederlands Tijdschrift voor Hematologie, vol. 13, no. 3, pp. 95-100.